Den Europæiske Union - dansk - EMA (European Medicines Agency)

novartis europharm limited  - lutetium (177lu) vipivotide tetraxetan - prostatic neoplasmer, kastration-resistent - terapeutiske radioaktive lægemidler - pluvicto in combination with androgen deprivation therapy (adt) with or without androgen receptor (ar) pathway inhibition is indicated for the treatment of adult patients with progressive prostate-specific membrane antigen (psma)-positive metastatic castration-resistant prostate cancer (mcrpc) who have been treated with ar pathway inhibition and taxane based chemotherapy.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

smartpractice denmark aps - alfa-amylcinnamaldehyd, almindelig slåenlav (evernia prunastri), benzocain, benzylparahydroxybenzoat, butylparahydroxybenzoat, chlorquinaldol, cinchocainhydrochlorid, cinnamaldehyd, cinnamylalkohol, clioquinol, cyclohexylbenzothiazylsulfenamid, dibenzothiazyldisulfid, dipentamethylenthiuramdisulfid, diphenylguanidin, disulfiram, epoxyresin, ethylendiamindihydrochlorid, ethylparahydroxybenzoat, eugenol, geraniol, hydroxycitronellal, isoeugenol, kaliumdichromat, koboltchlorid, kolofonium, lanolinalkohol, mercaptobenzothiazol, methylchlorisothiazolinon, methylparahydroxybenzoat, morpholinylmercaptobenzothiazol, n-cyclohexyl-n-phenylparaphenylendiamin, n-hydroxymethylsuccinimid, n-isopropyl-n-phenylparaphenylendiamin, n,n-diphenylparaphenylendiamin, neomycinsulfat, nikkelsulfat, p-tert butylphenol formaldehyd harpiks, paraphenylendiamin, perubalsam, propylparahydroxybenzoat, quaternium-15, tetracainhydrochlorid, tetramethylthiurammonosulfid, thiomersal, thiram, zinkdibutyldithiocarbamat, zinkdiethyldithiocarbamat - plaster til provokationstest

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

smartpractice denmark aps - alfa-amylcinnamaldehyd, almindelig slåenlav (evernia prunastri), bacitracin, benzocain, benzylparahydroxybenzoat, bronopol, budesonid, butylparahydroxybenzoat, cinnamaldehyd, cinnamylalkohol, clioquinol, cyclohexylbenzothiazylsulfenamid, diazolidinyl urea, dibenzothiazyldisulfid, dipentamethylenthiuramdisulfid, diphenylguanidin, disperse blue 106, disulfiram, epoxyresin, ethylendiamindihydrochlorid, ethylparahydroxybenzoat, eugenol, geraniol, guldnatriumthiosulfat, hydrocortisonbutyrat, hydroxycitronellal, imidurea, isoeugenol, kaliumdichromat, koboltchlorid, kolofonium, lanolinalkohol, mercaptobenzothiazol, methylchlorisothiazolinon, methyldibromoglutharonitrile, methylparahydroxybenzoat, morpholinylmercaptobenzothiazol, n-cyclohexyl-n-phenylparaphenylendiamin, n-hydroxymethylsuccinimid, n-isopropyl-n-phenylparaphenylendiamin, n,n-diphenylparaphenylendiamin, neomycinsulfat, nikkelsulfat, p-tert butylphenol formaldehyd harpiks, paraphenylendiamin, parthenolid, perubalsam, propylparahydroxybenzoat, quaternium-15, tetracainhydrochlorid, tetramethylthiurammonosulfid, thiomersal, thiram, tixocortolpivalat, zinkdibutyldithiocarbamat, zinkdiethyldithiocarbamat - plaster til provokationstest

Den Europæiske Union - dansk - EMA (European Medicines Agency)

pinnacle biologics b.v.  - porfimer natrium - barretts esophagus - antineoplastiske midler - fotodynamisk terapi (pdt) med photobarr er indiceret til: ablation af høj kvalitet dysplasi (hgd) hos patienter med barretts Øsofagus (bo).

Den Europæiske Union - dansk - EMA (European Medicines Agency)

novartis europharm limited  - gozetotide - radionuklidbilleddannelse - diagnostiske radioaktive lægemidler - dette lægemiddel er kun til diagnostisk brug. locametz, after radiolabelling with gallium 68, is indicated for the detection of prostate specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high risk pca prior to primary curative therapy,suspected pca recurrence in patients with increasing levels of serum prostate specific antigen (psa) after primary curative therapy,identification of patients with psma positive progressive metastatic castration resistant prostate cancer (mcrpc) for whom psma targeted therapy is indicated (see section 4.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

cis bio international - samarium (153sm) lexidronam pentasodium - pain; cancer - terapeutiske radioaktive lægemidler - quadramet er indiceret til lindring af knoglesmerter hos patienter med flere smertefulde osteoblastic knogle metastaser, der fylder technetium [99mtc]-mærket biphosphonates på knoglescanning. tilstedeværelsen af osteoblastic metastaser, som kan tage op technetium [99mtc]-mærket biphosphonates skal være bekræftet forud for terapi.

Danmark - dansk - SEGES Landbrug & Fødevarer

upl europe ltd. (tidligere: united phosphorus ltd.) - sprede-klæbemiddel - flydende middel - 1000 g/l sprede-klæbemiddel

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

ge healthcare as - gadoterinsyre - injektionsvæske, opløsning - 279,3 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

ge healthcare as - gadoterinsyre - injektionsvæske, opløsning i fyldt injektionssprøjte - 279,3 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

smartpractice denmark aps - alfa-amylcinnamaldehyd, almindelig slåenlav (evernia prunastri), benzocain, benzylparahydroxybenzoat, butylparahydroxybenzoat, chlorquinaldol, cinchocainhydrochlorid, cinnamaldehyd, cinnamylalkohol, clioquinol, cyclohexylbenzothiazylsulfenamid, dibenzothiazyldisulfid, dipentamethylenthiuramdisulfid, diphenylguanidin, disulfiram, epoxyresin, ethylendiamindihydrochlorid, ethylparahydroxybenzoat, eugenol, geraniol, hydroxycitronellal, isoeugenol, kaliumdichromat, koboltchlorid, kolofonium, lanolinalkohol, merc - plaster til provokationstest